Kinetic parameters for small-molecule drug delivery by covalent cell surface targeting

Biochimica et Biophysica Acta - General Subjects

Volumn 1568, Issue 2, 2001, Pages 147-154

  Nauman, David A ^a   Bertozzi, Carolyn R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b USA   (United States)

Author keywords

Cancer; Drug delivery; Glycosylation; Metabolic engineering; Sialic acid

Indexed keywords

GLYCOCONJUGATE; KETONE DERIVATIVE; MANNOSAMINE; MONOCLONAL ANTIBODY; N LEVULINOYLMANNOSAMINE; N LEVULINOYLSIALIC ACID; SIALIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CELL SURFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; COVALENT BOND; CULTURE MEDIUM; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DRUG DELIVERY SYSTEM; ELECTRIC POTENTIAL; HUMAN; HUMAN CELL; HYDROLYSIS; INCUBATION TIME; KINETICS; LEUKEMIA CELL LINE; LIGATION; MATHEMATICAL MODEL; PRIORITY JOURNAL; QUANTITATIVE ASSAY; TARGET CELL;

BIOTIN; CELL MEMBRANE; CELLS, CULTURED; DRUG DELIVERY SYSTEMS; FLOW CYTOMETRY; HEXOSAMINES; HUMANS; JURKAT CELLS; KETONES; KINETICS; MODELS, CHEMICAL; SIALIC ACIDS; TIME FACTORS;

EID: 0035814482     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(01)00211-2     Document Type: Article

References (32)

1. Tumor heterogeneity and immunotherapy of cancer
2. Monoclonal antibodies in drug targeting
3. Novel therapeutic strategies to selectively kill cancer cells
4. Cytotoxic agents directed to peptide hormone receptors: Defining the requirements for a successful drug
5. Multi-drug delivery system using streptavidin-transforming growth factor-alpha chimeric protein
6. Therapeutic efficacy of a doxorubicin immunoconjugate in a preclinical model of spontaneous metastatic human melanoma
7. Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates
8. Antitumor activity of the single-chain immunotoxin BR96 sFv-PE40 against established breast and lung tumor xenografts
9. Antibody-directed enzyme prodrug therapy: Efficacy and mechanism of action in colorectal carcinoma
10. Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model
11. 2 in patients with non-resectable liver metastases from colorectal cancer
12. Improved intratumoral penetration of radiolabeled streptavidin in intraperitoneal tumors pretargeted with biotinylated antibody
13. Chemoselective approaches to glycoprotein assembly
14. Chemoselective ligation reactions with proteins, oligosaccharides and cells
15. Selective radioactive labeling of cell surface sialoglycoproteins by periodate-tritiated borohydride
16. In vitro attachment of mono- and oligosaccharides to surface glycoconjugates of intact cells
17. Engineering chemical reactivity on cell surfaces through oligosaccharide biosynthesis
18. Metabolic delivery of ketone groups to sialic acid residues. Application to cell surface glycoform engineering
19. Exploiting differences in sialoside expression for selective targeting of MRI contrast reagents
20. Engineering novel cell surface receptors for virus-mediated gene transfer
21. Possible roles of tumor-associated carbohydrate antigens
22. Sialylation and malignant potential in tumour cell glycosylation mutants
23. Characterization of rapid membrane internalization and recycling
24. (6-Maleimidocaproyl)hydrazone of doxorubicin - A new derivative for the preparation of immunoconjugates of doxorubicin
25. Reduced temperature prevents transfer of a membrane glycoprotein to the cell surface but does not prevent terminal glycosylation
26. 125I-asialofetuin by the perfused rat liver
27. Studies on the mechanism of oxime and semicarbazone formation
28. Membrane transport in the endocytic pathway
29. 1 treatment retards transferrin receptor recycling more than bulk membrane recycling
30. On the mechanism of schiff base formation and hydrolysis
31. Monoclonal antibody conjugates of doxorubicin prepared with branched linkers: A novel method for increasing the potency of doxorubicin immunoconjugates